🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Part 1 determined: aliskiren, amlodipine and angiotensin II concentrations ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2007-06
Trial ID
NCT00498433
Treatments Being Tested
The purpose of this study was to evaluate the effect of celecoxib on the ef...
Status
Completed
Location
Oldfield Surgery
Start Date
2016-11-03
Trial ID
NCT02979197
The purpose of this study is to prevent major cardiovascular events (heart ...
Status
Completed
Location
Minneapolis Medical Research Foundation
Start Date
1999-09
Trial ID
NCT00000620
The purpose of this study is to demonstrate the antihypertensive efficacy o...
Status
Completed
Location
Clinical Investigative Site 4000
Start Date
2011-02
Trial ID
NCT01264692
Treatments Being Tested
The purpose of this study was to evaluate the effect of celecoxib on the ef...
Status
Completed
Location
Celerion
Start Date
2014-06-26
Trial ID
NCT02172040
This study will determine whether using losartan and amlodipine together wi...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-30
Trial ID
NCT01277822
The purpose of this study is to evaluate the efficacy and safety of TCV-116...
Status
Withdrawn
Location
Fuwai Hospital
Start Date
2017-05-09
Trial ID
NCT02969265
Treatments Being Tested
This is a multi-centre, randomised, double-blind, active-controlled, parall...
Status
Completed
Location
1348.1.015 Boehringer Ingelheim Investigational Site
Start Date
2013-11
Trial ID
NCT01975246
Treatments Being Tested
This study evaluated the safety and efficacy of the fixed combination of va...
Status
Completed
Location
Beijing ChaoYang Hospital, Affiliate of Capital University of Medical Sciences
Start Date
2007-01
Trial ID
NCT00413413
Treatments Being Tested
The purpose of this study is to evaluate the effect of zilebesiran on systo...
Status
Completed
Location
Clinical Trial Site
Start Date
2021-11-05
Trial ID
NCT05103332
Treatments Being Tested